Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma
Condition(s):Mantle Cell Lymphoma RecurrentLast Updated:March 25, 2011Unknown status
Hide Studies Not Open or Pending
Condition(s):Mantle Cell Lymphoma RecurrentLast Updated:March 25, 2011Unknown status
Condition(s):Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin LymphomaLast Updated:August 7, 2018Completed
Condition(s):LymphomaLast Updated:December 7, 2011Completed
Condition(s):Recurrent Mantle Cell LymphomaLast Updated:February 5, 2024Active, not recruiting
Condition(s):Recurrent Mantle Cell LymphomaLast Updated:October 30, 2018Completed
Condition(s):Recurrent Mantle Cell LymphomaLast Updated:April 17, 2014Completed
Condition(s):Recurrent Mantle Cell LymphomaLast Updated:April 3, 2014Completed
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:February 21, 2024Active, not recruiting
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:January 18, 2024Recruiting
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:December 15, 2023Suspended
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.